regn2222
mAbexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started May 1, 2014 (NCT02121080)
Timeline
Indications
Mechanism of action
- RSV F-proteinImmunity, passive
RSV F-protein immunity, passive
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- regn2222
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02828397 | Phase 1 | Apr 1, 2016 | Regeneron |
| NCT02325791 | Phase 3 | Jun 1, 2015 | Regeneron |
| NCT02121080 | Phase 1 | May 1, 2014 | Regeneron |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Regeneron | For profit | 3 | 3 | 2 | 2014 |
1 organizations
Page 1 / 1